Biotechnology Engineer in Oncology
The position is part of an INCa-funded project to study the impact of chemotherapies on protein synthesis and tumor cell plasticity. It is located at the Centre de Recherche en Cancérologie de Lyon (CRCL) (directed by P Mehlen), an internationally renowned center dedicated to innovative oncology research (www.crcl.fr). The engineer will be integrated into the “Ribosome, Translation and Cancer” team, headed by Dr. Jean-Jacques Diaz. The team explores the role of protein synthesis and ribosomes in tumor pathology. --> Deadline for application, 1 May 2025
Related tags:
SHARE